[1]
YuX., LiuJ., QiuH., HaoH., ZhuJ. and PengS. 2020. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences. (Jun. 2020). DOI:https://doi.org/10.17305/bjbms.2020.4746.